Earnings Call · Q2 FY2026·2026-07-29

Q2 26EPS +7.81%·Rev n/aQ1 26EPS +6.60%·Rev n/aQ4 25EPS -9.19%·Rev n/aQ3 25EPS -1.86%·Rev n/a⚠ consensus missing

CHEMED CORP CHE

Holley Schmidt — Assistant Controller

Kevin McNamara — President and Chief Executive Officer

Mike Witzeman — Chief Financial Officer

Joel Wherley — President and Chief Executive Officer, ChemEd VITAS Healthcare Corporation

+4.2%1d on move date3d+2.8%5d+4.3%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CHE calls or request research access.

More CHE calls Browse calls Request research access